SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-16-006631
Filing Date
2016-01-06
Accepted
2016-01-06 06:14:16
Documents
33
Period of Report
2015-08-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm 10-K/A 685097
  Complete submission text file 0001493152-16-006631.txt   1580161

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE ptlf-20150831.xml EX-101.INS 108494
3 XBRL SCHEMA FILE ptlf-20150831.xsd EX-101.SCH 15161
4 XBRL CALCULATION FILE ptlf-20150831_cal.xml EX-101.CAL 22079
5 XBRL DEFINITION FILE ptlf-20150831_def.xml EX-101.DEF 32666
6 XBRL LABEL FILE ptlf-20150831_lab.xml EX-101.LAB 114097
7 XBRL PRESENTATION FILE ptlf-20150831_pre.xml EX-101.PRE 85239
Mailing Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210
Business Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210 (310) 279-5152
PetLife Pharmaceuticals, Inc. (Filer) CIK: 0001354591 (see all company filings)

IRS No.: 331133537 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K/A | Act: 34 | File No.: 000-52445 | Film No.: 161325304
SIC: 2860 Industrial Organic Chemicals